|
| | | | |
|
 | | REBUILDER MEDICAL TECHNOLOGIES, INC. TO ENTER THE ENERGY DRINK MARKET WITH ITS NUTRITIONALLY-SOUND RESTORE PRODUCT | | | ReBuilder Medical Technologies, Inc. | | 06/09/2007 | | | Company to go head-to-head with popular brands such as Red Bull
ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) today announced plans to introduce its ReStore into the lucrative energy drink market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
Initially, ReStore -- an all-natural, sugar-free energy supplement -- was being marketed as a supplement and energy drink that is both safe and beneficial for diabetics and those suffering from sub-clinical depression. However, the company decided to take steps toward repositioning the product when consumers who were also familiar with the mass-market energy beverage, Red Bull, expressed a preference for ReStore.
"Originally we looked at this product only for diabetic patients who use our ReBuilder System for diabetic peripheral neuropathy because it has no sugar," said ReBuilder Medical Technologies, Inc., CEO David B. Phillips, Ph.D. "An informal field test in Tampa, Florida in June of 2006 indicated that of 212 people who tasted Red Bull, 178 overwhelmingly preferred the taste and the effect of ReStore." Of 17 subjects who tried both products for 3 days, only 2 preferred Red Bull, 3 did not like either, and 12 preferred the ReStore product.
The market for ReStore has increased with each quarter, even though ReStore was only offered to ReBuilder customers as a nutritional supplement to increase their energy and improve their mood. Income from ReStore has gone from just a few thousand dollars in 2003 to $10,000 in 2006. "We expect to be at $30,000 in sales before the end of the year 2007 expires, as a result of the taste preference for ReStore. After that, we hope to use word of mouth, viral marketing to increase sales to challenge Red Bull," says Phillips. Red Bull, the Austrian-produced energy drink and current world market leader, saw sales in excess of $1 billion last year alone.
"We intend to meet with marketing executives whose companies market Red Bull and other energy beverages, including Southland Corporation, regional chains and Wal-Mart," said Phillips. "The ReStore formula, under license, has been marketed since 1992 as an anti-depressive formula supplied by psychologists for sub-clinical depression," said Brian Sheldon, Director of Clinical Studies. "It lifts the mood and provides four hours of productive energy with absolutely no side effects."
ReStore is produced in a powder form that can be mixed into any favorite drink such as orange juice or cranberry juice.
The ReBuilder System is an electronic device that restores nerve function, increases blood flow, cancels pain, and reduces numbness and tingling. The device is available via the Internet.
Twenty million, eight hundred thousand children and adults, or 7% of the U.S. population suffer from diabetes. Thirty percent of those diagnosed with diabetes will eventually suffer from peripheral neuropathy, pain and numbness in the feet and hands that can lead to complete loss of mobility, gangrene, and eventual amputations. $132 Billion per year is the current cost of treating diabetes, or 1 of every 10 health care dollars spent. Neuropathy sufferers constitute 33% of this market, or 43.56 billion dollars in potential market. ReBuilder Medical Technologies, Inc. is a company in its infancy that has targeted 1% of this market, or, $43.5 million dollars in its next two market years, and expects to meet this goal. Its primary competition is from drug companies. Drug therapy has proven far less successful, and is prone to side effects and addiction issues.
For product and company information, see: http://www.rebuildermedical.com.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of emerging medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered ReBuilder System, used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum, which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. Its CEO, Dr. David B. Phillips, is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles. The company is also involved in research and development on a number of other innovative products.
More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward- looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.
SOURCE ReBuilder Medical Technologies, Inc. | |
|
| | | View similar articles: | | |
| | | |
|
 | People who viewed this article were also interested in |  | |  |
|
| Other articles from ReBuilder Medical Technologies, Inc. | | | |
|